FDA Accepts DACOGEN® (Decitabine) sNDA Submission in Acute Myeloid Leukemia 13 July 2011/in 2011, News /by webadminFDA Accepts DACOGEN® (Decitabine) sNDA Submission in Acute Myeloid Leukemia /wp-content/uploads/2019/11/logo_white.png 0 0 webadmin /wp-content/uploads/2019/11/logo_white.png webadmin2011-07-13 14:34:122016-11-24 14:53:11FDA Accepts DACOGEN® (Decitabine) sNDA Submission in Acute Myeloid Leukemia